apl. Prof. Dr. Udo Gaipl



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Combinations of radiotherapy with vaccination and immune checkpoint inhibition differently affect primary and abscopal tumor growth and the tumor microenvironment (2021) Rückert M, Deloch L, Frey B, Schlücker E, Fietkau R, Gaipl U Journal article Head and neck tumor cells treated with hypofractionated irradiation die via apoptosis and are better taken up by M1-like macrophages (2021) Wedekind H, Walz K, Buchbender M, Rieckmann T, Strasser E, Grottker F, Fietkau R, et al. Journal article Radioimmuntherapie (2021) Hecht M, Gaipl U, Fietkau R Journal article, Review article Gas plasma irradiation of breast cancers promotes immunogenicity, tumor reduction, and an abscopal effect in vivo (2021) Mahdikia H, Saadati F, Freund E, Gaipl U, Majidzadeh-a K, Shokri B, Bekeschus S Journal article Radon exposure—therapeutic effect and cancer risk (2021) Maier A, Wiedemann J, Rapp F, Papenfuß F, Rödel F, Hehlgans S, Gaipl U, et al. Journal article, Review article Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis (2020) Tajik N, Frech M, Schulz O, Schälter F, Lucas S, Azizov V, Dürholz K, et al. Journal article Radiomics for selection of patients treated with immuno-radiotherapy: pooled analysis from 6 studies (2020) Sun R, Sundahl N, Hecht M, Putz F, Lancia A, Milic M, Carre A, et al. Conference contribution Reactivation of HCMV during RT of the brain results in critical illness and early mortality (2020) Frey B, Goerig N, Becker I, Donaubauer AJ, Korn K, Überla K, Schmidt M, et al. Conference contribution Development of a flow cytometry-based whole-blood prognostic immune signature in metastatic cancer patients treated with immune checkpoint inhibitors (2020) Zhou J, Donaubauer AJ, Frey B, Becker I, Rutzner S, Eckstein M, Sun R, et al. Conference contribution Identification of nine lncRNAs signature for predicting survival benefit of melanoma patients treated with immune checkpoint inhibitors (2020) Zhou JG, Ma H, Gaipl U Conference contribution